Advance Research

Advance Research

We are working to drive research to better treatments, and ultimately a cure, as quickly as possible

From basic science to clinical trial designs, the National Brain Tumor Society partners with the world’s leaders in research, public policy, and clinical care to advance the understanding of brain tumors, expand the availability of new treatments, and drive the discovery of a cure. With targeted programs for both adult and pediatric brain tumors, as well as other strategic initiatives to improve access and approvals of newfound discoveries, we drive bold, innovative programs to ensure a brighter future.

Integrated Initiatives

Integrated Initiatives

Uniquely poised to drive change and progress throughout the drug discovery and development pipeline, our initiatives and programs further knowledge and deliver results to our community.

Our funding strategy

Our Funding Strategy

Driven by the needs of this community, we have funded more than $30 million dollars of promising and innovative research for both adults and pediatric brain tumors.

Research funding opportunities

Funding Opportunities

Our innovative funding models are designed to support rigorous scientific investigation and drive progress toward treatments and the discovery of a cure.


From the Blog

  • July 18, 2017

    [INFOGRAPHIC] Defeat GBM By The Numbers

    At the end of June, we published our 2017 Defeat GBM Research Collaborative Progress Report. Accompanying this comprehensive report on the impact of this flagship research program, were a blog recapping the cumu

    Read More

  • July 17, 2017

    Top Five Blogs: April – June 2017

    In the brain tumor community, the second quarter of the year (Q2: April – June) is always a busy time…if for no other reason than Brain Tumor Awareness Month (May) sits smack-dab in the middle of it. And this year was no

    Read More

  • June 27, 2017

    Defeat GBM Research Collaborative Progress Report: A Multitude of New Discoveries & A Push to Evaluate Potential New Drugs in Clinical Trials

    National Brain Tumor Society shares updates on the portfolio of progress being made through its subsidiary, Cure GBM, LLC, and its flagship program, the Defeat GBM Research Collaborative Today, we would like to p

    Read More

More from the blog